Business
Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development
Former Microsoft and SomaLogic executives join senior leadership team of company developing platform for comprehensively quantifying the proteome SEATTLE,
About this update from Nautilus Biotechnology, Inc.
[{"type":"text","content":"Former Microsoft and SomaLogic executives join senior leadership team of company developing platform for comprehensively quantifying the proteome\nSEATTLE, April 12, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointments of Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development, adding further experience to its senior leadership team in its ongoing expansion of the organization. Gwen Weld, Chief People Officer Gwen Weld brings to Nautilus more than 25 years of senior leadership in human resources, organizational culture, and business strategy. Immediately prior to joining the company, Ms. Weld served as Interim Chief People Officer at Amperity. She previously held the positions of Vice President of Global People and Infrastructure at Isilon Systems for more than six years and General Manager of Human Resources at Microsoft Corporation for nearly twenty years, leading Microsoft’s human resources agenda for its various groups and overseeing worldwide recruiting and alternative staffing. Ms. Weld studied business administration at Pace University. “Gwen’s breadth and depth of experience makes her extraordinarily well-suited to help us scale out a world-class team, deepen our high-performance culture, and do so in a way that creates an inclusive, driven, and highly collaborative work environment at Nautilus,” said Sujal Patel, co-founder and CEO of Nautilus. “I am thrilled to work with Gwen as we prioritize building a people-first culture that supports our growing teams as they deliver transformative technologies into the world.” Sheri Wilcox, Ph.D., Vice President of Affinity Reagent Development Sheri Wilcox, Ph.D., joins Nautilus from SomaLogic, where she was instrumental in the development of the SomaScan Platform and SOMAmer reagents over 21 years at the company and most recently served as Senior Director of Global Scientific Engagement. Dr. Wilcox advanced through positions of increasing responsibility at SomaLogic, including Associate Director of Aptamer Discovery where she guided research of aptamers for biomarker discovery and directed the high-throughput generation of SOMAmer reagents, and Senior Director of Analyti...